[Double-blind study of naftidrofuryl-hydrogen oxalate in peripheral arterial occlusive disease].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005663:Furans / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009257:Nafronyl / Q000627:therapeutic use*; D010919:Placebos; D014665:Vasodilator Agents / Q000627:therapeutic use*
D005663:Furans; D010919:Placebos; D014665:Vasodilator Agents; D009257:Nafronyl
Doppelblindstudie mit Naftidrofuryl-Hydrogenoxalat.